Ken‐ichi Hosoya

9.2k citations
217 papers · 7.5k indexed · 1 hit paper · h-index 46
Topics
Drug Transport and Resistance Mechanisms (87 papers)Amino Acid Enzymes and Metabolism (60 papers)Metabolism and Genetic Disorders (34 papers)
Partner nations
JapanUnited StatesPoland

In The Last Decade

Ken‐ichi Hosoya

212 papers receiving 7.3k citations

Hit Papers

Chromatographic Characterization of Silica C18 Packing Ma...19892026200120131989100200300400

Peers

Ken‐ichi Hosoya
Comparison fields: 5 of 128
  • Molecular Biology 2.5k
  • Oncology 2.1k
  • Biochemistry 1.2k
  • Pediatrics, Perinatology and Child Health 1.2k
  • Neurology 995
Replace Masanori Tachikawa with:
Masanori Tachikawa Japan
Sumio Ohtsuki Japan
Mark A. Yorek United States
Hitomi Takanaga Japan
Cecília M. P. Rodrigues Portugal
Takuji Shirasawa Japan
Masamitsu Shimazawa Japan
Thomas P. Misko United States
Yasuo Ido United States
Robert W. Caldwell United States
Ken‐ichi Hosoya relative to Masanori Tachikawa Japan Masanori Tachikawa's profile →
Citations per field
00.5×
Masanori Tachikawa · 1×
Citations per year

Countries citing papers authored by Ken‐ichi Hosoya

Since Specialization
Citations

This map shows the geographic impact of Ken‐ichi Hosoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Hosoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Hosoya more than expected).

Fields of papers citing papers by Ken‐ichi Hosoya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Hosoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Hosoya. The network helps show where Ken‐ichi Hosoya may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Hosoya

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Hosoya. A scholar is included among the top collaborators of Ken‐ichi Hosoya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Hosoya. Ken‐ichi Hosoya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 1
4 4
5 6
6 23
7 15
8 10
9 16
10 14
11 19
12 47
13 32
14 40
15 34
16 84
17
Downregulation of retinal GLUT1 in diabetes by the ubiquitin proteasome pathway
1
18 101
19
Overexpression of GLUT1 and Increased Glucose Transport Leads to Apoptosis in Retinal Endothelial Cells
1
20 79

About Ken‐ichi Hosoya

Ken‐ichi Hosoya is a scholar working on Biochemistry, Clinical Biochemistry and Oncology, having authored 217 papers that have together received 7.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (87 papers), Amino Acid Enzymes and Metabolism (60 papers) and Metabolism and Genetic Disorders (34 papers). The work is most often cited by research in Biochemistry (1.2k citations), Neurology (995 citations) and Clinical Biochemistry (792 citations). Ken‐ichi Hosoya has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Tetsuya Terasaki, Sumio Ohtsuki, Masanori Tachikawa, Masatoshi Tomi, Hitomi Takanaga, Shin‐ichi Akanuma, Yoshiyuki Kubo, Kwang‐Jin Kim, Satoko Hori and Vincent H.L. Lee. Their work appears in journals such as Journal of Neuroscience, PLoS ONE and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026